Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 17/20 | 0.50 |
| ▸ | F2 | P00734 | 11/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 5/20 | 0.43 |
| ▸ | PLG | P00747 | 4/20 | 0.42 |
| ▸ | PLAU | P00749 | 4/20 | 0.42 |
| ▸ | ST14 | Q9Y5Y6 | 4/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7039793 | 0.89 | HRH3 (0.43) | F10F2PRSS1PLGPLAU | |
| SCHEMBL6130337 | 0.86 | F10 (0.51) | F10F2PRSS1PLGPLAU | |
| SCHEMBL7063308 | 0.86 | CHRM3 (0.40) | F10F2PRSS1PLGPLAU | |
| SCHEMBL6751808 | 0.80 | CCR5 (0.44) | PLAU | |
| SCHEMBL7659032 | 0.79 | PRSS1 (0.49) | F10F2PRSS1PLG | |
| SCHEMBL6130348 | 0.77 | F10 (0.50) | F10F2PRSS1PLGPLAU | |
| Hydrochloric Acid SCHEMBL6130310 | 0.76 | F10 (0.49) | F10F2PRSS1PLGPLAU | |
| SCHEMBL6752053 | 0.76 | F10 (0.42) | F10F2PRSS1PLGPLAU | |
| SCHEMBL7667899 | 0.76 | LOXL2 (0.56) | F10F2PRSS1PLG | |
| Hydrochloric Acid SCHEMBL6130303 | 0.76 | F10 (0.49) | F10F2PRSS1PLGPLAU |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030203935-A1 | Cyanobiphenyl derivatives | TEIJIN LIMITED | 2003-10-30 | — | — | US | disclosed |
| US-6538137-B1 | Blood-coagulation factor X inhibitors | TEIJIN LIMITED (JP) | 2003-03-25 | — | — | US | disclosed |
| EP-1179527-A1 | CYANOBIPHENYL DERIVATIVES | TEIJIN LIMITED (JP) | 2002-02-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203935-A1 | Cyanobiphenyl derivatives | F9, F12, F11 | F10 7/4885F2 4/4885PRSS1 633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.